United States Biotechnology & Medical Research

Rapt Therapeutics Inc (RAPT)

Track

Track

Ticker: RAPT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rapt Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.1
Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
226.91
Quantity 52,673 +1.3%
Value US$3,479,264
2.1
Brockstedt Dirk G. Officer Officer
Transaction date
Proposed sale
Price
488.02
Quantity 43,599
Value US$1,783,186
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
453.18
Quantity 35,595 +20.6%
Value US$373,175
1.3
HO WILLIAM Officer Officer
Transaction date
Proposed sale
Price
21.68
Quantity 2,500
Value US$54,200
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
13.72
Quantity 1,500 -7.9%
Value US$20,580
1.3
HO WILLIAM Officer Officer
Transaction date
Proposed sale
Price
13.72
Quantity 1,500
Value US$20,580
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.77
Quantity 2,500 -11.7%
Value US$39,425
1.3
HO WILLIAM Officer Officer
Transaction date
Proposed sale
Price
15.77
Quantity 2,500
Value US$39,425
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.92
Quantity 2,500 -10.5%
Value US$47,300
1.3
HO WILLIAM Officer Officer
Transaction date
Proposed sale
Price
18.92
Quantity 2,500
Value US$47,300
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.88
Quantity 5,000 -19.2%
Value US$94,400
1.3
HO WILLIAM Officer Officer
Transaction date
Proposed sale
Price
18.88
Quantity 5,000
Value US$94,400
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
20.05
Quantity 2,500 +62.5%
Value US$50,125
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
19.95
Quantity 600 +4.2%
Value US$11,970
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
18.48
Quantity 400 +2.9%
Value US$7,392
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
18.75
Quantity 1,500 +12.1%
Value US$28,125
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.62
Quantity 5,000 -16.4%
Value US$148,100
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 5,000 -14.3%
Value US$150,000
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.56
Quantity 5,000 -12.5%
Value US$127,800
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Sale
Price
21.97
Quantity 742 -3.7%
Value US$16,299
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.03
Quantity 5,000 -11.7%
Value US$90,150
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.87
Quantity 5,000 -10.5%
Value US$89,350
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.32
Quantity 5,000 -9.5%
Value US$111,600
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
21.52
Quantity 2,000 -3.7%
Value US$43,040
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.13
Quantity 2,500 -4.5%
Value US$70,325
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Sale
Price
19.95
Quantity 2,000 -3.7%
Value US$39,900
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.45
Quantity 63 +0.1%
Value US$785
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.45
Quantity 1,837 +0.1%
Value US$22,880
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.45
Quantity 63 +0.1%
Value US$785
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.45
Quantity 1,837 +0.1%
Value US$22,880
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 538 +1.3%
Value US$6,457
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 15,776 +1.3%
Value US$189,345
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 538 +1.3%
Value US$6,457
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 15,776 +1.3%
Value US$189,345
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.50
Quantity 338 +0.8%
Value US$4,225
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.50
Quantity 9,898 +0.8%
Value US$123,718
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.50
Quantity 338 +0.8%
Value US$4,225
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
12.50
Quantity 9,898 +0.8%
Value US$123,718
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
10.67
Quantity 41,250 +inf%
Value US$440,199
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
10.67
Quantity 1,208,750 +inf%
Value US$12,899,176
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
10.62
Quantity 400 +11.1%
Value US$4,248
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
10.49
Quantity 600 +20.0%
Value US$6,294
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
10.51
Quantity 1,000 +50.0%
Value US$10,510
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
11.30
Quantity 500 +38.5%
Value US$5,650
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
11.80
Quantity 2,500 +22.1%
Value US$29,500
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
10.54
Quantity 2,000 +21.5%
Value US$21,080
Young Rodney KB Chief Financial Officer Officer
Transaction date
Planned purchase
Price
10.53
Quantity 5,000 +98.3%
Value US$52,650
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
10.67
Quantity 41,250 +inf%
Value US$440,199
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Purchase
Price
10.67
Quantity 1,208,750 +inf%
Value US$12,899,176
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.05
Quantity 720 -3.5%
Value US$10,836
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
23.05
Quantity 2,647 -11.8%
Value US$61,013
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.96
Quantity 3,000 -5.3%
Value US$68,880
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
23.91
Quantity 2,648 -11.8%
Value US$63,314
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.79
Quantity 3,000 -5.1%
Value US$56,370
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
22.47
Quantity 2,647 -11.8%
Value US$59,478
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.67
Quantity 3,000 -4.9%
Value US$92,010
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
32.16
Quantity 2,648 -11.8%
Value US$85,160
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
40.00
Quantity 2,000 -3.2%
Value US$80,000
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
30.88
Quantity 2,647 -11.8%
Value US$81,739
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
32.26
Quantity 3,000 -5.0%
Value US$96,780
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
35.69
Quantity 2,648 -11.8%
Value US$94,507
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
30.70
Quantity 500 +5.7%
Value US$15,350
4.0
Robbins Wendye Non-Executive Director
Transaction date
Purchase
Price
29.69
Quantity 400 +4.8%
Value US$11,876
1.3
HO WILLIAM Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.69
Quantity 3,000 -4.8%
Value US$89,070
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
30.78
Quantity 2,647 -11.8%
Value US$81,475
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
34.94
Quantity 625 -100.0%
Value US$21,840
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
34.97
Quantity 1,114 -100.0%
Value US$38,951
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
34.48
Quantity 7,500 -100.0%
Value US$258,606
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
35.28
Quantity 4,788 -11.6%
Value US$168,942
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
35.27
Quantity 4,726 -6.1%
Value US$166,692
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
35.25
Quantity 4,803 -6.2%
Value US$169,309
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
35.19
Quantity 7,231 -14.9%
Value US$254,494
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
35.19
Quantity 7,320 -8.7%
Value US$257,572
3.8
COLUMN GROUP II, LP Large shareholder
Transaction date
Sale
Price
35.19
Quantity 7,187 -8.5%
Value US$252,940
2.1
Brockstedt Dirk G. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
35.78
Quantity 2,648 -11.8%
Value US$94,745
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-08 2024-01-05 PlS Planned sale
2.1
Brockstedt Dirk G.

CHIEF SCIENTIFIC OFFICER

Officer
52,673 +1.3%
226.91
US$3,479,264 		52,673 +1.3% 226.91 US$3,479,264
2024-01-05 2024-01-05 PrS Proposed sale
2.1
Brockstedt Dirk G.

Officer

Officer
43,599
488.02
US$1,783,186 		43,599 488.02 US$1,783,186
2023-12-22 2023-12-21 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
35,595 +20.6%
453.18
US$373,175 		35,595 +20.6% 453.18 US$373,175
2023-12-21 2023-12-21 PrS Proposed sale
1.3
HO WILLIAM

Officer

Officer
2,500
21.68
US$54,200 		2,500 21.68 US$54,200
2023-11-29 2023-11-28 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
1,500 -7.9%
13.72
US$20,580 		1,500 -7.9% 13.72 US$20,580
2023-11-28 2023-11-28 PrS Proposed sale
1.3
HO WILLIAM

Officer

Officer
1,500
13.72
US$20,580 		1,500 13.72 US$20,580
2023-10-04 2023-10-03 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
2,500 -11.7%
15.77
US$39,425 		2,500 -11.7% 15.77 US$39,425
2023-10-03 2023-10-03 PrS Proposed sale
1.3
HO WILLIAM

Officer

Officer
2,500
15.77
US$39,425 		2,500 15.77 US$39,425
2023-08-22 2023-08-18 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
2,500 -10.5%
18.92
US$47,300 		2,500 -10.5% 18.92 US$47,300
2023-08-18 2023-08-18 PrS Proposed sale
1.3
HO WILLIAM

Officer

Officer
2,500
18.92
US$47,300 		2,500 18.92 US$47,300
2023-04-20 2023-04-19 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
5,000 -19.2%
18.88
US$94,400 		5,000 -19.2% 18.88 US$94,400
2023-04-19 2023-04-19 PrS Proposed sale
1.3
HO WILLIAM

Officer

Officer
5,000
18.88
US$94,400 		5,000 18.88 US$94,400
2023-03-15 2023-03-14 B Purchase
4.0
Robbins Wendye
Non-Executive Director
2,500 +62.5%
20.05
US$50,125 		2,500 +62.5% 20.05 US$50,125
2023-03-15 2023-03-14 B Purchase
4.0
Robbins Wendye
Non-Executive Director
600 +4.2%
19.95
US$11,970 		600 +4.2% 19.95 US$11,970
2023-03-15 2023-03-14 B Purchase
4.0
Robbins Wendye
Non-Executive Director
400 +2.9%
18.48
US$7,392 		400 +2.9% 18.48 US$7,392
2023-03-15 2023-03-14 B Purchase
4.0
Robbins Wendye
Non-Executive Director
1,500 +12.1%
18.75
US$28,125 		1,500 +12.1% 18.75 US$28,125
2023-03-13 2023-03-07 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
5,000 -16.4%
29.62
US$148,100 		5,000 -16.4% 29.62 US$148,100
2023-01-26 2023-01-24 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
5,000 -14.3%
30.00
US$150,000 		5,000 -14.3% 30.00 US$150,000
2023-01-20 2023-01-19 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
5,000 -12.5%
25.56
US$127,800 		5,000 -12.5% 25.56 US$127,800
2023-01-09 2023-01-05 S Sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
742 -3.7%
21.97
US$16,299 		742 -3.7% 21.97 US$16,299
2022-12-30 2022-12-29 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
5,000 -11.7%
18.03
US$90,150 		5,000 -11.7% 18.03 US$90,150
2022-11-29 2022-11-28 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
5,000 -10.5%
17.87
US$89,350 		5,000 -10.5% 17.87 US$89,350
2022-11-03 2022-11-02 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
5,000 -9.5%
22.32
US$111,600 		5,000 -9.5% 22.32 US$111,600
2022-10-14 2022-10-13 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
2,000 -3.7%
21.52
US$43,040 		2,000 -3.7% 21.52 US$43,040
2022-08-31 2022-08-30 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
2,500 -4.5%
28.13
US$70,325 		2,500 -4.5% 28.13 US$70,325
2022-07-13 2022-07-11 S Sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
2,000 -3.7%
19.95
US$39,900 		2,000 -3.7% 19.95 US$39,900
2022-05-27 2022-05-25 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
63 +0.1%
12.45
US$785 		63 +0.1% 12.45 US$785
2022-05-27 2022-05-25 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
1,837 +0.1%
12.45
US$22,880 		1,837 +0.1% 12.45 US$22,880
2022-05-27 2022-05-25 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
63 +0.1%
12.45
US$785 		63 +0.1% 12.45 US$785
2022-05-27 2022-05-25 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
1,837 +0.1%
12.45
US$22,880 		1,837 +0.1% 12.45 US$22,880
2022-05-25 2022-05-24 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
538 +1.3%
12.00
US$6,457 		538 +1.3% 12.00 US$6,457
2022-05-25 2022-05-24 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
15,776 +1.3%
12.00
US$189,345 		15,776 +1.3% 12.00 US$189,345
2022-05-25 2022-05-24 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
538 +1.3%
12.00
US$6,457 		538 +1.3% 12.00 US$6,457
2022-05-25 2022-05-24 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
15,776 +1.3%
12.00
US$189,345 		15,776 +1.3% 12.00 US$189,345
2022-05-25 2022-05-23 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
338 +0.8%
12.50
US$4,225 		338 +0.8% 12.50 US$4,225
2022-05-25 2022-05-23 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
9,898 +0.8%
12.50
US$123,718 		9,898 +0.8% 12.50 US$123,718
2022-05-25 2022-05-23 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
338 +0.8%
12.50
US$4,225 		338 +0.8% 12.50 US$4,225
2022-05-25 2022-05-23 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
9,898 +0.8%
12.50
US$123,718 		9,898 +0.8% 12.50 US$123,718
2022-05-12 2022-05-10 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
41,250 +inf%
10.67
US$440,199 		41,250 +inf% 10.67 US$440,199
2022-05-12 2022-05-10 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
1,208,750 +inf%
10.67
US$12,899,176 		1,208,750 +inf% 10.67 US$12,899,176
2022-05-12 2022-05-10 B Purchase
4.0
Robbins Wendye
Non-Executive Director
400 +11.1%
10.62
US$4,248 		400 +11.1% 10.62 US$4,248
2022-05-12 2022-05-10 B Purchase
4.0
Robbins Wendye
Non-Executive Director
600 +20.0%
10.49
US$6,294 		600 +20.0% 10.49 US$6,294
2022-05-12 2022-05-10 B Purchase
4.0
Robbins Wendye
Non-Executive Director
1,000 +50.0%
10.51
US$10,510 		1,000 +50.0% 10.51 US$10,510
2022-05-12 2022-05-10 B Purchase
4.0
Robbins Wendye
Non-Executive Director
500 +38.5%
11.30
US$5,650 		500 +38.5% 11.30 US$5,650
2022-05-12 2022-05-10 B Purchase
4.0
Robbins Wendye
Non-Executive Director
2,500 +22.1%
11.80
US$29,500 		2,500 +22.1% 11.80 US$29,500
2022-05-12 2022-05-10 B Purchase
4.0
Robbins Wendye
Non-Executive Director
2,000 +21.5%
10.54
US$21,080 		2,000 +21.5% 10.54 US$21,080
2022-05-12 2022-05-10 PP Planned purchase
Young Rodney KB

Chief Financial Officer

Officer
5,000 +98.3%
10.53
US$52,650 		5,000 +98.3% 10.53 US$52,650
2022-05-12 2022-05-10 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
41,250 +inf%
10.67
US$440,199 		41,250 +inf% 10.67 US$440,199
2022-05-12 2022-05-10 B Purchase
3.8
COLUMN GROUP II, LP
Large shareholder
1,208,750 +inf%
10.67
US$12,899,176 		1,208,750 +inf% 10.67 US$12,899,176
2022-05-05 2022-05-04 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
720 -3.5%
15.05
US$10,836 		720 -3.5% 15.05 US$10,836
2022-04-12 2022-04-11 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
23.05
US$61,013 		2,647 -11.8% 23.05 US$61,013
2022-04-07 2022-04-06 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
3,000 -5.3%
22.96
US$68,880 		3,000 -5.3% 22.96 US$68,880
2022-03-14 2022-03-11 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
23.91
US$63,314 		2,648 -11.8% 23.91 US$63,314
2022-02-28 2022-02-28 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
3,000 -5.1%
18.79
US$56,370 		3,000 -5.1% 18.79 US$56,370
2022-02-14 2022-02-11 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
22.47
US$59,478 		2,647 -11.8% 22.47 US$59,478
2022-01-14 2022-01-13 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
3,000 -4.9%
30.67
US$92,010 		3,000 -4.9% 30.67 US$92,010
2022-01-13 2022-01-11 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
32.16
US$85,160 		2,648 -11.8% 32.16 US$85,160
2022-01-06 2022-01-05 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
2,000 -3.2%
40.00
US$80,000 		2,000 -3.2% 40.00 US$80,000
2021-12-13 2021-12-10 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
30.88
US$81,739 		2,647 -11.8% 30.88 US$81,739
2021-12-06 2021-12-03 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
3,000 -5.0%
32.26
US$96,780 		3,000 -5.0% 32.26 US$96,780
2021-12-10 2021-11-11 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
35.69
US$94,507 		2,648 -11.8% 35.69 US$94,507
2021-10-19 2021-10-18 B Purchase
4.0
Robbins Wendye
Non-Executive Director
500 +5.7%
30.70
US$15,350 		500 +5.7% 30.70 US$15,350
2021-10-15 2021-10-13 B Purchase
4.0
Robbins Wendye
Non-Executive Director
400 +4.8%
29.69
US$11,876 		400 +4.8% 29.69 US$11,876
2021-10-14 2021-10-13 PlS Planned sale
1.3
HO WILLIAM

Chief Medical Officer

Officer
3,000 -4.8%
29.69
US$89,070 		3,000 -4.8% 29.69 US$89,070
2021-10-12 2021-10-11 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,647 -11.8%
30.78
US$81,475 		2,647 -11.8% 30.78 US$81,475
2021-09-29 2021-09-27 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
625 -100.0%
34.94
US$21,840 		625 -100.0% 34.94 US$21,840
2021-09-29 2021-09-27 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
1,114 -100.0%
34.97
US$38,951 		1,114 -100.0% 34.97 US$38,951
2021-09-29 2021-09-27 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
7,500 -100.0%
34.48
US$258,606 		7,500 -100.0% 34.48 US$258,606
2021-09-14 2021-09-13 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
4,788 -11.6%
35.28
US$168,942 		4,788 -11.6% 35.28 US$168,942
2021-09-14 2021-09-13 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
4,726 -6.1%
35.27
US$166,692 		4,726 -6.1% 35.27 US$166,692
2021-09-14 2021-09-13 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
4,803 -6.2%
35.25
US$169,309 		4,803 -6.2% 35.25 US$169,309
2021-09-14 2021-09-10 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
7,231 -14.9%
35.19
US$254,494 		7,231 -14.9% 35.19 US$254,494
2021-09-14 2021-09-10 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
7,320 -8.7%
35.19
US$257,572 		7,320 -8.7% 35.19 US$257,572
2021-09-14 2021-09-10 S Sale
3.8
COLUMN GROUP II, LP
Large shareholder
7,187 -8.5%
35.19
US$252,940 		7,187 -8.5% 35.19 US$252,940
2021-09-13 2021-09-10 PlS Planned sale
2.1
Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
35.78
US$94,745 		2,648 -11.8% 35.78 US$94,745
Explore more

More insider trading research around Rapt Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America